6-(3-(Pyrrolidin-1-yl)propoxy)-2-phenylbenzo[d]oxazole

ID: ALA4088775

PubChem CID: 137642761

Max Phase: Preclinical

Molecular Formula: C20H22N2O2

Molecular Weight: 322.41

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  c1ccc(-c2nc3ccc(OCCCN4CCCC4)cc3o2)cc1

Standard InChI:  InChI=1S/C20H22N2O2/c1-2-7-16(8-3-1)20-21-18-10-9-17(15-19(18)24-20)23-14-6-13-22-11-4-5-12-22/h1-3,7-10,15H,4-6,11-14H2

Standard InChI Key:  CEMLVWCAMWKAPN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   13.9146  -12.3284    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3988  -11.6710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9146  -11.0053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1373  -11.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1373  -12.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4241  -12.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7150  -12.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7150  -11.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4241  -10.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2201  -11.6710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6287  -10.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4501  -10.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8587  -11.6710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4501  -12.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6287  -12.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0059  -12.4882    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2968  -12.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5836  -12.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8745  -12.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1655  -12.4882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0814  -13.3039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2789  -13.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8662  -12.7650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4182  -12.1581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  4  9  2  0
  5  6  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
  2 10  1  0
 17 18  1  0
 18 19  1  0
 16 17  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 20 24  1  0
 19 20  1  0
  7 16  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4088775

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 322.41

Molecular Weight (Monoisotopic): 322.1681

AlogP: 4.36

#Rotatable Bonds: 6

Polar Surface Area: 38.50

Molecular Species: BASE

HBA: 4

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.27

CX LogP: 3.67

CX LogD: 1.81

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.63

Np Likeness Score: -1.54

References

1. Roy S, Mukherjee A, Paul B, Rahaman O, Roy S, Maithri G, Ramya B, Pal S, Ganguly D, Talukdar A..  (2017)  Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism.,  134  [PMID:28437629] [10.1016/j.ejmech.2017.03.086]

Source

Source(1):

• Scientific Literature